BMRN
BioMarin Pharmaceutical Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -8.3% ·
aliran saham -0.3% ·
posisi baru bersih -9.1%
· formula
Distribusi luas: saham yang turun dan pemegang yang lebih sedikit
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 1.42M | $84.45M | n/a | n/a |
| Q2 2026 | 135 | +4 | 146.70M | $8.39B | +11 | −8 |
| Q1 2026 | 135 | -4 | 142.18M | $8.03B | +5 | −10 |
| Q4 2025 | 138 | +3 | 154.93M | $9.20B | +4 | n/a |
| Q3 2025 | 23 | -1 | 108.93M | $5.90B | n/a | −2 |
| Q2 2025 | 22 | -2 | 113.78M | $6.25B | n/a | −2 |
| Q1 2025 | 21 | 0 | 70.58M | $4.99B | +1 | −1 |
| Q4 2024 | 21 | +1 | 67.83M | $4.46B | +1 | n/a |
| Q3 2024 | 19 | 0 | 57.19M | $4.02B | +2 | −2 |
| Q2 2024 | 19 | n/a | 53.80M | $4.43B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasif) | 24.00M | n/a | $1.32B | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 2 | The Vanguard Group ✦ (pasif) | 19.00M | n/a | $1.04B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 3 | PRIMECAP Management ✦ | 15.77M | -11.3% | $867.00M | 0.7% | ▼ Trim | 5 | SEC ↗ |
| 4 | Dodge & Cox ✦ | 15.11M | +1.0% | $830.50M | 0.5% | ▲ Add | 5 | SEC ↗ |
| 5 | Viking Global Investors ✦ | 12.29M | +13.8% | $675.50M | 2.0% | ▲ Add | 5 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (pasif) | 8.85M | +4.5% | $486.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 5.58M | +90.7% | $306.43M | 0.3% | ▲ Add | 5 | SEC ↗ ×7 |
| 8 | Geode Capital Management ✦ (pasif) | 3.47M | +1.3% | $190.42M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 2.83M | +319.7% | $155.80M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | Norges Bank ✦ (pasif) | 2.04M | -38.2% | $112.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.81M | +101.7% | $99.32M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.12M | +104.4% | $61.32M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | Fidelity (FMR) ✦ | 546.10K | n/a | $30.02M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 14 | Citadel Advisors ✦ | 335.02K | -79.0% | $18.42M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | Arrowstreet Capital ✦ | 278.64K | +27.8% | $15.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 227.75K | +84.2% | $12.52M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 147.60K | -80.6% | $8.11M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 137.93K | +4.2% | $7.58M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 19 | Gotham Asset Management ✦ | 119.45K | +151.6% | $6.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Marshall Wace ✦ | 83.85K | +484.9% | $4.61M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 21 | Fisher Asset Management ✦ | 13.54K | -0.2% | $744,581 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | GAMCO Investors ✦ | 8.00K | -3.5% | $439,760 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Elliott Investment Management | $247.44M | adalah 2.3% |
| Point72 Asset Management | $27.98M | adalah 0.1% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 549 pemegang, 183.01M saham, $10.09B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 17.56K lbr · $1.16M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi